Related Experiment Video
Updated: Jun 13, 2025
Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts
Published on: February 11, 2014
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints
Ekaterina Laukhtina1, Marco Moschini2, Jeremy Yuen-Chun Teoh3
1Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Purpose Of Review:
This review explores the design and endpoints of perioperative platforms in clinical trials for muscle-invasive bladder cancer (MIBC).
Recent Findings:
The choice of clinical trial design in perioperative platforms for MIBC must align with specific research objectives to ensure robust and meaningful outcomes. Novel designs in perioperative platforms for MIBC integrate bladder-sparing approaches. Primary endpoints such as pathological complete response and disease-free survival are highlighted for their role in expediting trial results in perioperative setting. Incorporating patient-reported outcomes is important to inform healthcare decision makers about the outcomes most meaningful to patients. Given the growing body of evidence, potential biomarkers, predictive and prognostic tools should be considered and implemented when designing trials in perioperative platforms for MIBC.
Summary:
Effective perioperative platforms for MIBC trials are critical in enhancing patient outcomes. The careful selection and standardization of study designs and endpoints in the perioperative platform are essential for the successful implementation of new therapies and the advancement of personalized treatment approaches in MIBC.
Insights
Designing clinical trials for muscle-invasive bladder cancer (MIBC) requires careful selection of perioperative platforms and endpoints. Standardized approaches enhance new therapy implementation and personalized treatment for better patient outcomes.
Area of Science:
- Oncology
- Clinical Trial Design
- Urologic Oncology
Background:
- Muscle-invasive bladder cancer (MIBC) necessitates innovative treatment strategies.
- Perioperative approaches are increasingly central to MIBC management.
- Optimizing clinical trial design is crucial for advancing MIBC care.
Purpose of the Study:
- To review the design and endpoints of perioperative platforms in clinical trials for MIBC.
- To highlight the importance of aligning trial design with research objectives.
- To explore novel designs integrating bladder-sparing approaches.
Main Methods:
- Literature review of perioperative clinical trials in MIBC.
- Analysis of study designs and endpoint selection.
- Synthesis of findings on trial optimization.
Main Results:
- Perioperative platform design must match research goals for robust outcomes.
- Novel designs incorporate bladder-sparing strategies.
- Key endpoints include pathological complete response and disease-free survival.
- Patient-reported outcomes and biomarkers are vital considerations.
Conclusions:
- Effective perioperative platforms are essential for improving MIBC patient outcomes.
- Standardized designs and endpoints facilitate new therapy implementation.
- This approach advances personalized treatment strategies for MIBC.
